Redx Pharma PLC (LSE:REDX) - Overview

Stock Report

Redx Pharma PLC REDX

Last Price
GBX43.00

Day Change
0.00|0.00%

As of 02/12/2016
15:56:58 GMT | GBX
Minimum 15 Minutes Delay.

Last Close43.00p
Day Range42.00 - 44.00
Mkt Cap40.29Mil
52-Wk Range23.00 - 80.50
Yield %0.00
ISINGB00BSNB6S51
Volume61,226
P/E-2.75
P/SInfinity
P/CF-3.81

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
Redx Pharma PLC-8.51 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-3.33-4.01-9.43
Net Profit-3.19-3.35-8.18
Reported EPS-4.91-5.16-14.10
Balance Sheet
Current Assets5.006.4412.34
Non Current Assets0.640.441.41
Total Assets5.647.0613.76
Current Liabilities4.865.244.06
Total Liabilities4.865.246.06
Total Equity0.781.827.70
Cash Flow
Operating Cash Flow-4.14-2.57-6.65
Net Change in Cash0.971.866.54
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-12.39-14.38--2.99---
2017-14.14-13.86--3.10---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
04/04/2016Exercise of OptionMr. Philip Tottey42.5035,29415,000.00

Company Profile

Redx Pharma PLC through its subsidiaries is a drug discovery and development company. The Company develops proprietary, small molecule therapeutics to address areas of unmet medical need principally in two areas, cancer and infectious disease.
 

Sector

Biotechnology

Market Position

1126 of 1865 Companies

Index

FTSE AIM All Share

Outlook

(24/02/2016) "We continue to view prospects for the business with confidence"

Next Event 20/01/2017

Next prelim announcement
Ratios
CompSecMkt
More ...
PER (E)-3.1013.1416.27
Div Yld (E)0.004.184.36
PEG (E)0.000.360.00
ROCE-99.83206.9680.66
Op Mrgn0.00-17.09-14.86
EPS Grwth0.009.6525.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Frank Armstrong
Chief Executive OfficerDr. Neil Murray
Finance Director (Interim)Andrew Booth
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.